Skip to content
Delayed ~15 min

AGEN AGENUS INC

Health Care · Russell 2000

Next earnings: not announced yet

What 6 analyst firms say about AGENUS INC: their latest ratings, price targets and how far the stock is from them. How it works

7.15 USD+0.71 (+11.02%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+242.7%to the avg target 24.50 USD+17.35 USD
Buy 4 · Hold 1 · Sell 0

5 rated views · 6 analyst/firm records · 6 firms

Latest report22 Oct 2026avg report date 21 Sep
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8045
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8029

Recent analyst activity · last 90 days

Our tracked history has 8 reports on AGEN from 5 analyst firms in the last 90 days (6 firms in the past year).

Comparing each firm's latest target with its previous one: 1 lowered it, 2 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: H.C. Wainwright lowered its target from $30.00 (set 13 Jul 2026) to $25.00 on 11 Aug 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
B Riley SecuritiesMayank MamtaniBuy24 Sep 202614.00 USD
Chardan Capital MarketsAndreas ArgyridesBuy22 Oct 202640.00 USD
H.C. WainwrightEmily BodnarBuy11 Aug 202625.00 USD
Rodman & RenshawMichael KingBuy28 Sep 202619.00 USD
Weiss RatingsUnnamed analyst—8 Oct 2026—
Data feed RESEARCHResearch TeamHold11 May 2026Conflicting reports · excluded

Partial coverage · checked 6 Nov (6 Nov 2026, 07:07 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.